Cargando…

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial

We examined the effects of a dihydropyridine calcium channel blocker nilvadipine with anti-inflammatory properties on cognition and cerebrospinal fluid (CSF) biomarkers by baseline Alzheimer's disease (AD) severity. Exploratory analyses were performed on the dataset (n = 497) of a phase III ran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdullah, Laila, Crawford, Fiona, Tsolaki, Magda, Börjesson-Hanson, Anne, Olde Rikkert, Marcel, Pasquier, Florence, Wallin, Anders, Kennelly, Sean, Ait-Ghezala, Ghania, Paris, Daniel, Hendrix, Suzanne, Blennow, Kaj, Lawlor, Brian, Mullan, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067750/ https://www.ncbi.nlm.nih.gov/pubmed/32210906 http://dx.doi.org/10.3389/fneur.2020.00149

Ejemplares similares

European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease—the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow
por: Meulenbroek, Olga, et al.
Publicado: (2016)

NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease
por: Lawlor, Brian, et al.
Publicado: (2014)

Gait speed, cognition and falls in people living with mild-to-moderate Alzheimer disease: data from NILVAD
por: Dyer, Adam H., et al.
Publicado: (2020)

Bacopa monnieri supplementation has no effect on serum brain-derived neurotrophic factor levels but beneficially modulates nuclear factor kappa B and cyclic AMP response element-binding protein levels in healthy elderly subjects
por: Keegan, Andrew P., et al.
Publicado: (2023)

MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer’s disease
por: Ringland, Charis, et al.
Publicado: (2021)

Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
por: Verma, Megha, et al.
Publicado: (2015)

Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
por: Verma, Megha, et al.
Publicado: (2015)

Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)

A fast, miniaturised in-vitro assay developed for quantification of lipase enzyme activity
por: Menden, Ariane, et al.
Publicado: (2019)

Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid
por: Luis, Cheryl A., et al.
Publicado: (2011)

Adaptive Immune Responses Associated with the Central Nervous System Pathology of Gulf War Illness
por: Nkiliza, Aurore, et al.
Publicado: (2021)

Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
por: Schweig, Jonas Elias, et al.
Publicado: (2017)

CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models
por: Laporte, Vincent, et al.
Publicado: (2006)

Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanism
por: Paris, Daniel, et al.
Publicado: (2011)

Gulf War Agent Exposure Causes Impairment of Long-Term Memory Formation and Neuropathological Changes in a Mouse Model of Gulf War Illness
por: Zakirova, Zuchra, et al.
Publicado: (2015)

A Chronic Longitudinal Characterization of Neurobehavioral and Neuropathological Cognitive Impairment in a Mouse Model of Gulf War Agent Exposure
por: Zakirova, Zuchra, et al.
Publicado: (2016)

Complementary proteomic approaches reveal mitochondrial dysfunction, immune and inflammatory dysregulation in a mouse model of Gulf War Illness
por: Zakirova, Zuchra, et al.
Publicado: (2017)

Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
por: Paris, Daniel, et al.
Publicado: (2010)

Lifelong behavioral and neuropathological consequences of repetitive mild traumatic brain injury
por: Mouzon, Benoit C., et al.
Publicado: (2017)

Impact of gulf war toxic exposures after mild traumatic brain injury
por: Ferguson, Scott, et al.
Publicado: (2022)

Proteomic Identification of Pathways Responsible for the Estradiol Therapeutic Window in AD Animal Models
por: Cui, Jie, et al.
Publicado: (2019)

Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
por: Johansson, Per, et al.
Publicado: (2013)

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
por: Blennow, Kaj
Publicado: (2017)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Phospholipid profiling of plasma from GW veterans and rodent models to identify potential biomarkers of Gulf War Illness
por: Emmerich, Tanja, et al.
Publicado: (2017)

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease
por: Jiang, Hong, et al.
Publicado: (2011)

Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease
por: Jeppsson, Anna, et al.
Publicado: (2022)

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
por: Mattsson, Niklas, et al.
Publicado: (2010)

Exogenous lipase administration alters gut microbiota composition and ameliorates Alzheimer’s disease-like pathology in APP/PS1 mice
por: Menden, Ariane, et al.
Publicado: (2022)

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases
por: Rosén, Christoffer, et al.
Publicado: (2011)

Should CSF Biomarkers Support a Routine Analysis for Early Diagnosis of Alzheimer's Disease?
por: Parnetti, Lucilla, et al.
Publicado: (2010)

CSF orexin-A levels after rituximab treatment in recent onset narcolepsy type 1
por: Wasling, Pontus, et al.
Publicado: (2019)

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
por: Lawlor, Brian, et al.
Publicado: (2018)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
por: Blennow, Kaj, et al.
Publicado: (2015)

Brain‐derived neurotropic factor polymorphisms, traumatic stress, mild traumatic brain injury, and combat exposure contribute to postdeployment traumatic stress
por: Dretsch, Michael N., et al.
Publicado: (2015)

Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers
por: Neselius, Sanna, et al.
Publicado: (2014)

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
por: Henjum, Kristi, et al.
Publicado: (2018)

CSF-Biomarkers in Olympic Boxing: Diagnosis and Effects of Repetitive Head Trauma
por: Neselius, Sanna, et al.
Publicado: (2012)

Increased CSF Levels of Phosphorylated Neurofilament Heavy Protein following Bout in Amateur Boxers
por: Neselius, Sanna, et al.
Publicado: (2013)

Repeated lumbar punctures within 3 days may affect CSF biomarker levels
por: Olsson, Martin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_464fin2da8ej1rtsndo7b8s2ra